Skip to main content
. 2017 Apr 12;25(6):359–364. doi: 10.1007/s12471-017-0986-z

Table 3.

Clinical follow-up parameters

Patient 1 Patient 2 Patient 3
3 months 6 months 3 months 6 months 3 months 6 months
Drop in mean office blood pressure (mm Hg) −31/+2 −62/−18 +8/−5 +28/+10 −50/−23 −30/−10
Drop in ambulatory blood pressure (mm Hg) −44/−28 −16/−22 −2/+3 −9/−4 −2/−4 −20/−12
Change in heart rate (bpm) 0 0 −8 −2 −19 −9
Change in eGFR (ml/min) 0 +5 +6 −5 0 0
Antihypertensive medication
Ace inhibitor Yes Yes No No No No
Angiotensin receptor blocker No No Yes Yes Yes Yes
Diuretic Yes, dose decreased Yes Yes Yes, dose increased No No
Calcium channel blocker Intolerant Intolerant Yes Yes No No
Alpha blocker No No Yes Yes No No
Beta blocker Yes Yes Yes Yes Yes Yes
Aldosterone receptor antagonist No Yes No No No No
Vasodilator No No No No No No
Adverse events
Death No No No No No No
Myocardial infarction No No No No No No
Stroke/TIA No No No No No No